In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Laura Davisson, MD, MPH, FACP, to discuss a recent article on the comparison of Metformin and lifestyle intervention in diabetes prevention. Topics covered include the success of the intensive lifestyle intervention of the Diabetes Prevention Program, the difficulty many patients have with weight loss maintenance, and the consideration of prescribing Metformin for prediabetes.
In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Medicine Association (OMA) Obesity Algorithm, which is a comprehensive review of obesity medicine that can be found at obesitymedicine.org. We then discuss this new science with obesity experts. To access other resources from the clinical leader in Obesity Medicine, visit: www.obesitymedicine.org.
Episode Guests
Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC
Resources Mentioned
In this episode, OMA Executive Director of Clinical Education, Dr. Nicholas Pennings is joined by Dr. Ethan Lazarus, 2021-2022 President of the OMA Board...
In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Dr. Treah Haggerty. Our experts...
Episode Description In this episode, the OMA Chief Science Officer, Harold Bays, MD, FOMA Dipl. ABOM interviews Karli Burridge, PA-C, MMS about the effects...